Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05497167 · ClinicalTrials.gov registry record · NA

Development and Evaluation of "Period Kits" for Adolescents With Intellectual and Developmental Disabilities

A NA study of Patient Empowerment and Autistic Spectrum Disorder, sponsored by Tufts Medical Center.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05497167 is a NA study of Patient Empowerment and Autistic Spectrum Disorder that has completed, run by Tufts Medical Center. The registered enrollment target is 50 participants, below the 229-participant average among 4 other Patient Empowerment trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05497167, a NA study of Patient Empowerment and Autistic Spectrum Disorder, has completed, sponsored by Tufts Medical Center.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study will involve the development, distribution, and evaluation of "period kits" for pre-menarchal adolescents with intellectual and cognitive disabilities (IDD) (e.g., autism spectrum disorder and Down syndrome) in relieving stress and augmenting sense of preparedness regarding imminent pubertal changes.

Interventions

  • OTHER Period Kit

Study Locations (1)

Massachusetts

  • Tufts Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2022-09-23
Est. Completion 2024-05-29
Phase NA

Sponsor

Tufts Medical Center

169 total trials

What the Registry Record Tells You About NCT05497167

The ClinicalTrials.gov registry entry for NCT05497167 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 229-participant average among 4 other Patient Empowerment trials with a reported enrollment target (78% lower). The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Patient Empowerment appearing as the primary indexed condition, and to 1 intervention - of which Period Kit is the first listed.

NCT05497167 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05497167 about?

NCT05497167 is a clinical study titled "Development and Evaluation of "Period Kits" for Adolescents With Intellectual and Developmental Disabilities". This study will involve the development, distribution, and evaluation of "period kits" for pre-menarchal adolescents with intellectual and cognitive disabilities (IDD) (e.g., autism spectrum disorder and Down syndrome) in relieving stress and augmenting sense of preparedness regarding imminent puber...

What is the current status of trial NCT05497167?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-09-23. Estimated completion is 2024-05-29.

What conditions does trial NCT05497167 study?

This clinical trial studies the following conditions: Patient Empowerment, Autistic Spectrum Disorder, Menstrual Discomfort.

What interventions are being tested in trial NCT05497167?

The interventions under investigation include: Period Kit (OTHER).

Who is sponsoring clinical trial NCT05497167?

This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05497167 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Patient Empowerment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.